Publication Name	World Journal of Hepatology
Manuscript ID	40718
Country	China

Received	2018-07-06 07:48
Peer-Review Started	2018-07-06 10:19
To Make the First Decision	2018-08-09 00:22
Return for Revision	2018-08-10 00:30
Revised	2018-08-14 14:34
Second Decision	2018-09-06 10:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-10-09 04:03
Articles in Press	2018-10-09 04:03
Publication Fee Transferred
Edit the Manuscript by Language Editor	2018-11-14 10:39
Typeset the Manuscript	2018-12-24 12:45
Publish the Manuscript Online	2018-12-27 09:28

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Stem cell transplantation for the treatment of end-stage liver disease
Manuscript Source	Invited Manuscript
All Author List	Dong-Bo Wu, En-Qiang Chen and Hong Tang
ORCID	Author(s) ORCID Number Dong-Bo Wu http://orcid.org/0000-0003-4500-047X En-Qiang Chen http://orcid.org/0000-0002-8523-1689 Hong Tang http://orcid.org/0000-0002-9790-6225
Funding Agency and Grant Number
Corresponding Author	En-Qiang Chen, MD, PhD, Associate Professor, Doctor, Doctor, Center of Infectious Diseases, West China Hospital of Sichuan University, No.37 Guo Xue Xiang, Wuhou District, Chengdu 610041, Sichuan Province, China. chenenqiang@scu.edu.cn
Key Words	Stem cell transplantation; End-stage liver disease; Clinical treatment; Efficacy; Safety
Core Tip	Stem cells have the capacity for multiple rounds of self-renewal and differentiation, and play important roles in numerous biological functions. Treatment of end-stage liver disease via stem cell transplantation has emerged as an effective therapeutic alternative in clinical practice. However, caution should be paid to ensuring the safety and efficacy of stem cell transplantation to avoid the use of products that are not rigorously tested that may put patients at risk.
Publish Date	2018-12-27 09:28
Citation	Wu DB, Chen EQ, Tang H. Stem cell transplantation for the treatment of end-stage liver disease. World J Hepatol 2018; 10(12): 907-910
URL	https://www.wjgnet.com/1948-5182/full/v10/i12/907.htm
DOI	https://dx.doi.org/10.4254/wjh.v10.i12.907

Full Article (PDF)	WJH-10-907.pdf
Full Article (Word)	WJH-10-907.doc
Manuscript File	40718-Review.docx
Answering Reviewers	40718-Answering reviewers.pdf
Audio Core Tip	40718-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	40718-Conflict-of-interest statement.pdf
Copyright License Agreement	40718-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	40718-Language certificate.pdf
Peer-review Report	40718-Peer-review(s).pdf
Scientific Misconduct Check	40718-Scientific misconduct check.pdf
Scientific Editor Work List	40718-Scientific editor work list.docx